Status:
COMPLETED
Predicting Rectal Adenoma With Canceration and Investigating Mechanism Based on Multimodal MRI and Biochemical Model
Lead Sponsor:
Aiyin Li
Conditions:
Rectal Adenoma
Eligibility:
All Genders
Brief Summary
In this retrospective study is to establish a diagnostic model for rectal adenoma canceration. The model will include multimodal comprehensive HR-T2WI morphological score, IVIM functional imaging and ...
Detailed Description
Imaging tests is the main method for evaluating rectal mass, especially MRI, which has been widely used in the preoperative diagnosis of rectal mass disease due to its very good soft tissue resolution...
Eligibility Criteria
Inclusion
- surgical resection
- pathologically confirmed rectal adenoma or rectal adenoma with canceration
- rectal MRI examination including IVIM-DWI, within two weeks before surgery
Exclusion
- preoperative treatment
- poor image quality, including intestinal gas or fecal artifact and IVIM image fitting error
- no surgical resection but colonoscopy
- pathologically confirmed rectal cancer.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06158776
Start Date
January 1 2022
End Date
June 15 2022
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qianfoshan Hosptial
Jinan, Shandong, China, 250014